Remepy (Series A)
Funding Details
Awarder
RSS - feeds.feedburner.com
Date Award
August 12, 2026
Vertical
Pharmaceuticals
Funding URL
View Funding Page
Funding Amount
$36,000,000
Company Info
Traction
This funding brings the total capital raised by the Company to $62 million.
Organizations Involved
Merck KGaA
Market
Healthcare
Location
New York, NY, USA
Coinvestors
O.G. Venture Partners, M Ventures, NFX, Vine Ventures, Qumra Capital, TechAviv, 97212 Ventures, Fresh Fund, PsyMed Ventures, Tadmor Group, Key1 Capital, IT-Farm Corp
Company Description

Remepy is the pioneer of Hybrid Drugs, focusing on pharmaceutical co-development partnerships and the expansion of its Hybrid Drug pipeline and platform.

Links
Website
Back to HomeBack to Pharmaceuticals DealsView Funding Announcement